Eos Advisory’s portfolio has reached a total valuation of £121m off the back of recent investment rounds and its first two exits, including Genus acquiring a large stake in aquaculture firm Xelect.
In January 2021, the St Andrews-based investment firm led a £1.2m investment into RAB-Microfluidics, an Aberdeen-headquartered company developing microfluidic technology to diagnose engine and turbine wear in real time.
The following month, Eos secured its first strategic investment partnership with US-based Kineticos Life Sciences, to co-invest in early stage Scottish companies. They aim to invest over £10m over the next five years in oncology-focused life sciences ventures.